What are the different types of lupus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Types of Lupus

Yes, there are distinct types of lupus, primarily divided into systemic lupus erythematosus (SLE), cutaneous lupus erythematosus (CLE), drug-induced lupus, and neonatal lupus, with CLE further subdivided into acute, subacute, chronic, and intermittent forms based on clinical presentation and duration of skin lesions. 1, 2

Major Categories of Lupus

Systemic Lupus Erythematosus (SLE)

  • SLE is a multisystem autoimmune disease that can affect any organ or tissue in the body, characterized by clinical heterogeneity and the presence of diverse autoantibodies. 3
  • The disease has an estimated prevalence of 20 to 150 cases per 100,000 population and is more common among women. 3
  • SLE may be better conceptualized as a syndrome rather than a single disease—a collection of signs, symptoms, and phenomena that occur together and suggest a particular abnormality, with varied phenotypes potentially representing different diseases sharing similar clinical presentations. 4

Cutaneous Lupus Erythematosus (CLE)

CLE represents a spectrum of disease ranging from isolated skin involvement to manifestations occurring as part of SLE. 1, 5

The Four Main Subtypes of CLE:

1. Acute Cutaneous Lupus Erythematosus (ACLE)

  • ACLE typically presents with the classic malar ("butterfly") rash and is most commonly associated with active systemic disease. 1, 2
  • These lesions are usually transient and resolve without scarring. 2

2. Subacute Cutaneous Lupus Erythematosus (SCLE)

  • SCLE manifests as photosensitive, annular or papulosquamous lesions, often in sun-exposed areas. 1, 2
  • Drug-induced SCLE is a recognized entity, with many common medications including antihypertensives capable of triggering this subtype through mechanisms involving the interferon-I pathway. 6
  • SCLE lesions typically heal without scarring but may leave dyspigmentation. 2

3. Chronic Cutaneous Lupus Erythematosus (CCLE)

  • Discoid lupus erythematosus (DLE) is the most common form of CCLE, presenting as well-defined, disc-shaped plaques with adherent scale, follicular plugging, and central atrophy. 1, 2
  • CCLE lesions are chronic and often result in permanent scarring, dyspigmentation, and alopecia when they affect the scalp. 2, 6
  • Other CCLE variants include lupus profundus (lupus panniculitis), chilblain lupus, and tumid lupus. 2

4. Intermittent Cutaneous Lupus Erythematosus (ICLE)

  • ICLE is characterized by recurrent episodes of skin lesions that resolve completely between flares. 2
  • This category was added to the Düsseldorf Classification to account for patients with episodic cutaneous manifestations. 2

Classification Framework

The Düsseldorf Classification System

  • The Düsseldorf Classification divides CLE into the four categories above based on clinical features, average duration of cutaneous lesions, histological changes, and laboratory abnormalities. 2
  • These subtypes can have overlapping clinical features, and distinct subtypes may coexist within the same patient. 2, 6

Lupus Nephritis Classification

When lupus affects the kidneys, a separate classification system applies:

  • The International Society of Nephrology/Renal Pathology Society (ISN/RPS) classification divides lupus nephritis into six histologic classes (I–VI), with the 2018 revision clarifying definitions to improve reproducibility. 7
  • Class I represents minimal mesangial disease detectable only by immunofluorescence or electron microscopy. 7
  • Class II involves mesangial proliferation with mesangial hypercellularity (≥4 mesangial cells per glomerular tuft). 3, 7
  • Class III is focal lupus nephritis affecting <50% of glomeruli. 7
  • Class IV is diffuse lupus nephritis affecting ≥50% of glomeruli and requires aggressive immunosuppression. 7
  • Class V is membranous lupus nephritis with subepithelial immune deposits. 7
  • Class VI represents advanced sclerosing disease with ≥90% glomerular sclerosis. 8

Diagnostic Considerations

Confirming CLE Diagnosis

  • It is essential to confirm a CLE diagnosis histopathologically by biopsy because there are several differential diagnoses and CLE is a chronic disease requiring regular follow-up and sometimes systemic treatment. 1
  • Direct immunofluorescence and photoprovocation testing may be applied to confirm the diagnosis in specific cases. 2

Distinguishing Between Types

  • Differentiation between CLE subtypes is based on clinical features and average duration of cutaneous lesions, but also considers histological changes from skin biopsy specimens and laboratory abnormalities. 2
  • A minimum of 10 glomeruli is required for adequate renal biopsy evaluation when lupus nephritis is suspected, with tissue processed for light microscopy, immunofluorescence, and electron microscopy. 7, 8

Clinical Implications

Risk of Systemic Progression

  • Patients with isolated CLE, particularly DLE, have a lower risk of developing systemic disease compared to those with ACLE or SCLE. 1
  • Regular monitoring for systemic involvement is essential, with heightened vigilance in Asian, African/Caribbean, Hispanic, and childhood-onset populations. 7

Common Pitfalls

  • Do not rely solely on clinical appearance to classify lupus type—histopathology and laboratory testing are essential for accurate diagnosis and appropriate treatment planning. 1, 2
  • Environmental triggers, particularly UV exposure and smoking, can induce and aggravate cutaneous lesions across all CLE subtypes. 6
  • The clinical and serological heterogeneity of lupus raises the question of whether SLE represents a single disease with varied phenotypes or multiple diseases sharing similar presentations—this conceptual framework may allow for more targeted therapies and personalized medicine approaches in the future. 4

References

Research

Cutaneous lupus erythematosus: An update.

Indian dermatology online journal, 2014

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Systemic lupus erythematosus one disease or many?

Autoimmunity reviews, 2012

Research

Clinical aspects of cutaneous lupus erythematosus.

Frontiers in medicine, 2022

Guideline

Lupus Nephritis – Evidence‑Based Diagnostic and Therapeutic Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnosing Lupus Nephritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.